144 related articles for article (PubMed ID: 7044528)
21. Trial of aminoglutethimide vs hydrocortisone as second-line hormone treatment of advanced breast cancer.
Mercer PM; Ebbs SR; Fraser SC; Coltart RS; Bates T
Eur J Surg Oncol; 1993 Jun; 19(3):254-8. PubMed ID: 8314383
[TBL] [Abstract][Full Text] [Related]
22. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer.
Santen RJ; Worgul TJ; Samojlik E; Interrante A; Boucher AE; Lipton A; Harvey HA; White DS; Smart E; Cox C; Wells SA
N Engl J Med; 1981 Sep; 305(10):545-51. PubMed ID: 7019703
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
Ingle JN; Green SJ; Ahmann DL; Long HJ; Edmonson JH; Rubin J; Chang MN; Creagan ET
J Clin Oncol; 1986 Jun; 4(6):958-64. PubMed ID: 3519885
[TBL] [Abstract][Full Text] [Related]
24. Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.
Hardy JR; Powles TJ; Judson IR; Sinnett HD; Ashley SE; Coombes RC; Ellin CL
Eur J Cancer; 1990; 26(7):824-7. PubMed ID: 2145904
[TBL] [Abstract][Full Text] [Related]
25. [Aminoglutethimide therapy in advanced breast cancer].
Kühböck J; Ludwig H; Pötzi P; Zielinski C
Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
[TBL] [Abstract][Full Text] [Related]
26. A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.
Milsted R; Habeshaw T; Kaye S; Sangster G; Macbeth F; Campbell-Ferguson J; Smith D; Calman K
Cancer Chemother Pharmacol; 1985; 14(3):272-3. PubMed ID: 3888433
[TBL] [Abstract][Full Text] [Related]
27. [Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt J; Rose C
Ugeskr Laeger; 1979 Jul; 141(31):2113-6. PubMed ID: 483409
[No Abstract] [Full Text] [Related]
28. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
[TBL] [Abstract][Full Text] [Related]
29. Clinical studies with aminoglutethimide in advanced breast carcinoma.
Harvey HA; Lipton A; Santen RJ
Acta Clin Belg Suppl; 1986; 11():29-40. PubMed ID: 3459321
[No Abstract] [Full Text] [Related]
30. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
[TBL] [Abstract][Full Text] [Related]
31. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.
Coombes RC; Powles TJ; Easton D; Chilvers C; Ford HT; Smith IE; McKinna A; White H; Bradbeer J; Yarnold J
Cancer Res; 1987 May; 47(9):2494-7. PubMed ID: 3552216
[TBL] [Abstract][Full Text] [Related]
34. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.
Nicolini A; Carpi A
Biomed Pharmacother; 2005 Jun; 59(5):253-63. PubMed ID: 15913946
[TBL] [Abstract][Full Text] [Related]
35. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
Cikes M
Schweiz Med Wochenschr; 1983 Mar; 113(11):382-91. PubMed ID: 6342129
[TBL] [Abstract][Full Text] [Related]
36. The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
Mouridsen HT; Robert NJ
Eur J Cancer; 2005 Aug; 41(12):1678-89. PubMed ID: 16098456
[TBL] [Abstract][Full Text] [Related]
37. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
Cataliotti L; Buzdar AU; Noguchi S; Bines J; Takatsuka Y; Petrakova K; Dube P; de Oliveira CT
Cancer; 2006 May; 106(10):2095-103. PubMed ID: 16598749
[TBL] [Abstract][Full Text] [Related]
38. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
39. A double blind randomised clinical trial of adjuvant aminoglutethimide versus placebo given to post menopausal patients with histologically confirmed stage II breast cancer.
Powles TJ; Coombes RC; Smith IE; Chilvers C; Easton D; Thomas L; Adcock H; Gazet JC; Nash AG; Bradbeer J
Breast Cancer Res Treat; 1986; 7 Suppl():S37-40. PubMed ID: 3527305
[TBL] [Abstract][Full Text] [Related]
40. Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey.
Budel VM; Paridaens RJ; Spetschinsky A; Heuson JC; Gompel C
Anticancer Res; 1986; 6(4):709-12. PubMed ID: 3752949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
